eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2010
vol. 2
 
Share:
Send email
Share:
abstract:

Case Reports
Case report
Tracheal cancer treated with a short course of external and endoluminal radio-chemotherapy combined with cetuximab – a case report

Aikaterini Papadopoulou
,
Marios Froudarakis
,
Ioannis Abatzoglou
,
Michael I. Koukourakis

J Contemp Brachyther 2010; 2, 4: 160-162
DOI: https://doi.org/10.5114/jcb.2010.19496
Online publish date: 2011/01/14
View full text Get citation
 
Primary tumors of the trachea are rare. Such cases are presented with acute respiratory distress demanding immediate therapeutic intervention. Herein, we present a case of an unresectable second primary tracheal cancer treated with intraluminal brachytherapy (8 Gy at 1 cm from catheter) followed by a short course of external beam hypofractionated radiotherapy (4.5 Gy × 4 fractions) and a final brachytherapy fraction (8 Gy), delivering a biological dose higher than 57.5 Gy (for / = 4 Gy) to the tumor within 4 weeks. Concurrent chemotherapy consisted of: fluoruracil (1000 mg/m2), leucovorin (100 mg/m2), oxaliplatin (80 mg/m2) and cetuximab (500 mg/m2), administered every two weeks for two consecutive cycles. Complete response was evident during the second brachytherapy fraction and the patient is alive with no evidence of disease, two years after therapy, without any late radiation sequel.
keywords:

brachytherapy, cetuximab, radiotherapy, trachea cancer

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.